Intellectual Property India Publishes Patent Application for 'Improved For The Of N-(4-(6,7-Dimethoxyquinolin-4-Yloxy)Phenyl)-N'-(4fluorophenyl)Cyclopropane-1,1-Dicarboxamide Fumarate' Filed by MSN Laboratories Private Limited, R&D Center

MUMBAI, India, Sept. 12 -- Intellectual Property India has published a patent application (202441016560 A) filed by MSN Laboratories Private Limited, R&D Center, Hyderabad, Telangana, on March 7, 2024, for 'improved for the of n-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-n'-(4fluorophenyl)cyclopropane-1,1-dicarboxamide fumarate.'

Inventor(s) include Srinivasan Thirumalai Rajan; Gade Srinivas Reddy; and Surigilla Venkateshwarlu.

The application for the patent was published on Sept. 12, under issue no. 37/2025.

According to the abstract released by the Intellectual Property India: "The present invention relates to an improved process for the preparation of N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide fumarate represented by the following structural formula-1, which is referred to as Cabozantinib fumarate. Formula-1 wherein n = 0.25 to 2.0."

Disclaimer: Curated by HT Syndication.